Northern Trust Corp Co Diagnostics, Inc. Transaction History
Northern Trust Corp
- $709 Billion
- Q2 2025
A detailed history of Northern Trust Corp transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 54,977 shares of CODX stock, worth $13,744. This represents 0.0% of its overall portfolio holdings.
Number of Shares
54,977
Previous 54,977
-0.0%
Holding current value
$13,744
Previous $17,000
11.76%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding CODX
# of Institutions
38Shares Held
4.96MCall Options Held
65.5KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.73MShares$433,3110.0% of portfolio
-
Private Advisory Group LLC Redmond, WA1.18MShares$295,4080.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny561KShares$140,2550.0% of portfolio
-
Black Rock Inc. New York, NY502KShares$125,5060.0% of portfolio
-
Geode Capital Management, LLC Boston, MA320KShares$79,9970.0% of portfolio
About Co-Diagnostics, Inc.
- Ticker CODX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 33,781,000
- Market Cap $8.45M
- Description
- Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...